相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Circadian Rhythm of Blood Pressure of Dipper and Non-dipper Patients With Essential Hypertension: A Mathematical Modeling Approach
Javiera Cortes-Rios et al.
FRONTIERS IN PHYSIOLOGY (2021)
Ingestion-time differences in the pharmacodynamics of hypertension medications: Systematic review of human chronopharmacology trials
Ramon C. Hermida et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Sensitivity and specificity of information criteria
John J. Dziak et al.
BRIEFINGS IN BIOINFORMATICS (2020)
Indirect pharmacodynamic models for responses with circadian removal
Vivaswath S. Ayyar et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2019)
ACC/AHA Versus ESC/ESH on Hypertension Guidelines
George Bakris et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention
Ramon C. Hermida et al.
EUROPEAN HEART JOURNAL (2018)
Circadian clock-mediated regulation of blood pressure
Lauren G. Douma et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/N MA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Chronotherapy for Hypertension
N. P. Bowles et al.
CURRENT HYPERTENSION REPORTS (2018)
Circadian mechanisms of 24-hour blood pressure regulation and patterning
Michael H. Smolensky et al.
SLEEP MEDICINE REVIEWS (2017)
Modeling Circadian Fluctuations of Pharmacokinetic Parameters
F. Veronneau-Veilleux et al.
MATHEMATICAL MODELLING OF NATURAL PHENOMENA (2017)
A pharmacokinetic/pharmacodynamic model of ACE inhibition of the renin-angiotensin system for normal and impaired renal function
Ashlee N. Ford Versypt et al.
COMPUTERS & CHEMICAL ENGINEERING (2017)
Identifying 24h variation in the pharmacokinetics of levofloxacin: a population pharmacokinetic approach
Laura Kervezee et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks
Ramon C. Hermida et al.
HYPERTENSION RESEARCH (2016)
Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients The Ambulatory Blood Pressure Collaboration in Patients With Hypertension (ABC-H) Meta-Analysis
Gil F. Salles et al.
HYPERTENSION (2016)
Safety of Immediate-Release Nifedipine
Laura Means et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2016)
Chronotherapeutics of Conventional Blood Pressure-Lowering Medications: Simple, Low-Cost Means of Improving Management and Treatment Outcomes of Hypertensive-Related Disorders
Ramon C. Hermida et al.
CURRENT HYPERTENSION REPORTS (2014)
ADMINISTRATION-TIME-DEPENDENT EFFECTS OF SPIRAPRIL ON AMBULATORY BLOOD PRESSURE IN UNCOMPLICATED ESSENTIAL HYPERTENSION
Ramon C. Hermida et al.
CHRONOBIOLOGY INTERNATIONAL (2010)
Morning Surge in Blood Pressure and Cardiovascular Risk Evidence and Perspectives
Kazuomi Kario
HYPERTENSION (2010)
Human Carboxymethylenebutenolidase as a Bioactivating Hydrolase of Olmesartan Medoxomil in Liver and Intestine
Tomoko Ishizuka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Assessing circadian rhythms in propofol PK and PD during prolonged infusion in ICU patients
Agnieszka Bienert et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2010)
Administration-Time-Dependent Effects of Olmesartan on the Ambulatory Blood Pressure of Essential Hypertension Patients
Ramon C. Hermida et al.
CHRONOBIOLOGY INTERNATIONAL (2009)
Comparative Pharmacodynamics of Olmesartan and Azelnidipine in Patients with Hypertension: a Population Pharmacokinetic/Pharmacodynamic Analysis
Yusuke Tanigawara et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Chronotherapy With the Angiotensin-Converting Enzyme Inhibitor Ramipril in Essential Hypertension Improved Blood Pressure Control With Bedtime Dosing
Ramon C. Hermida et al.
HYPERTENSION (2009)
24-Hour and Nighttime Blood Pressures in Type 2 Diabetic Hypertensive Patients Following Morning or Evening Administration of Olmesartan
Santiago Tofe Povedano et al.
JOURNAL OF CLINICAL HYPERTENSION (2009)
Pharmacokinetic/pharmacodynamic modeling of renin biomarkers in subjects treated with the renin inhibitor aliskiren
Y. Hong et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE
Claudio Ceconi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension
Ramon C. Hermida et al.
HYPERTENSION (2007)
Pharmacokinetic-pharmacodynamic modeling of telmisartan using an indirect response model in spontaneously hypertensive rats
Kun Hao et al.
ACTA PHARMACOLOGICA SINICA (2007)
A review of the structural and functional features of olmesartan medoxomil, an angiotensin receptor blocker
DE Mire et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Treatment of non-dipper hypertension with bedtime administration of valsartan
RC Hermida et al.
JOURNAL OF HYPERTENSION (2005)
Administration-time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure
RC Hermida et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2005)
Administration time-dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects
RC Hermida et al.
CHRONOBIOLOGY INTERNATIONAL (2005)
Risers and extreme-dippers of nocturnal blood pressure in hypertension: Antihypertensive strategy for nocturnal blood pressure
K Kario et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2004)
Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects
RC Hermida et al.
HYPERTENSION (2003)
Differential effects of morning or evening dosing of amlodipine on circadian blood pressure and heart rate
YG Qiu et al.
CARDIOVASCULAR DRUGS AND THERAPY (2003)
Relationship between physical activity and blood pressure in dipper and non-dipper hypertensive patients
RC Hermida et al.
JOURNAL OF HYPERTENSION (2002)
The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview
HR Brunner
JOURNAL OF HUMAN HYPERTENSION (2002)
Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors - An update
JC Song et al.
CLINICAL PHARMACOKINETICS (2002)
Comparison of angiotensin II receptor antagonists
W Kirch et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2001)
Practical identifiability analysis of large environmental simulation models
R Brun et al.
WATER RESOURCES RESEARCH (2001)
分享论文
